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UDP-glucose  4-epimerase  from Saccharomyces fra- 
gilis was inactivated  by  the arginine-specific reagents 
phenylglyoxal, 1,2-cyclohexanedione,  and 2,3-butane- 
dione following pseudo first order reaction kinetics. 
The  reaction  order with respect to phenylglyoxal was 
1.8 and  that with respect  to  the  other two diones was 
close to unity. Protection afforded by substrate and 
competitive  inhibitors  against  inactivation  by  phenyl- 
glyoxal and  the  reduced  interaction  of l-anilinonaph- 
thalene 8-sulfonic acid, a fluorescent probe for the 
substrate-binding  region after phenylglyoxal  modifi- 
cation, suggested  the  presence  of  an essential arginine 
residue at the  substrate-binding  region.  Experiments 
with [7-14C]phenylglyoxal  in  the  presence of UMP, a 
ligand  known to interact at the  substrate-binding re- 
gion, showed that only the arginine residue at the 
active site could be modified by phenylglyoxal. The 
characteristic  coenzyme  fluorescence  of  the  yeast en- 
zyme was found  to  be  enhanced  three  times  in  phenyl- 
glyoxal-inactivated enzyme suggesting the  incorpora- 
tion of the phenyl ring near the pyridine moiety of 
NAD. 
~~ 
UDP-glucose 4-epimerase (EC 5.1.3.2) is an obligatory en- 
zyme  of the galactose metabolic pathway. This enzyme cata- 
lyzes a freely reversible epimerization between UDP-glucose 
and UDP-galactose. Detailed and intensive study of this epi- 
merase from Escherichia  coli and from Saccharomyces fragilis 
by several groups of workers has clearly identified UDP-4- 
ketohexose and NADH as enzyme-bound intermediates  in the 
catalytic process, and  the enzyme is, therefore, mechanisti- 
cally classified as  an oxidoreductase (1, 2). In contrast to this 
extensive knowledge about the reaction mechanism of this 
enzyme, much less is known regarding its active site. There 
are, however, certain  interesting  features of this enzymatic 
reaction that  warrant closer attention  to  the problem of the 
mapping of the active site. Both the yeast (1,3,4) and  the E. 
coli enzymes (5) have only one coenzyme molecule for the 
dimeric apoenzyme and hence only one active site for the two 
subunits.  Important  questions of symmetry at  the active site 
and assembly of the holoenzyme remain unanswered. More- 
over, the epimerase is  the prototype of a class of oxidoreduc- 
tases that include such apparently dissimilar enzymes as 
TDP-glucose oxidoreductase and UDP-glucuronic acid decar- 
boxylase. Mechanistically, these enzymes are  all very similar, 
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since catalysis in each case proceeds through an initial  en- 
zyme-bound nucleotide 4-ketosugar and NADH  complex (6). 
Nothing  is known regarding the possible common and  distin- 
guishing features at  the active site of these enzymes. A sys- 
tematic study of the amino acid residues constituting the 
active site or participqting in the catalytic process for this 
enzyme may throw some light on some of these questions. We 
have recently demonstrated the presence of two  closely spaced 
and essential sulfhydryl groups at  the active site, each residing 
on the two different subunits that can be cross-linked through 
the formation of a disulfide bond under suitable oxidizing 
conditions (7). Employing a reconstituting system, elements 
of a dinucleotide fold, and a hydrophobic pocket for the 
adenosine subsite for the pyridine nucleotide-binding site of 
this enzyme has been recently detected (8,9). 
With the advent of specific arginine-modifying reagents 
such as phenylglyoxal (lo), 2,3-butanedione (ll), and 1,2- 
cyclohexanedione (12) a number of enzymes have been ex- 
amined for the involvement of arginine residues in the  cata- 
lytic mechanism (13-17). One plausible function of active site 
arginines is their  participation  in electrostatic binding of the 
anionic ligand to  the active site. Since the substrate of UDP- 
glucose 4-epimerase is negatively charged at cellular pH we 
have attempted to explore the possible involvement of argi- 
nine residues in  the function of this enzyme by using 1,2- 
cyclohexanedione, 2,3-butanedione, and phenylglyoxal as 
modifying reagents. The results described herein strongly 
suggest the presence of at least one essential arginine residue 
at  the substrate-binding region of the active site of UDP- 
galactose 4-epimerase. 
EXPERIMENTAL PROCEDURES 
Materials-1,2-Cyclohexanedione and 2,3-butanedione were prod- 
ucts of Aldrich. Phenylglyoxal and other biochemicals were purchased 
from Sigma. [7-’4C]Phenylglyoxal was purchased from Amersham 
Corp. Highly purified and essentially homogeneous UDP-glucose 4- 
epimerase from S. fragilis was prepared by  following up to stage I11 
of the method of Darrow and Rodstrom (3). Highly purified enzyme 
was also purchased from Sigma. The specific activity of the enzyme 
was usually between 10-15 units/mg of protein where 1 unit of enzyme 
could convert 1 pmol of UDP-galactose to UDP-glucose/min. The 
enzyme activity was assayed according to  the coupled assay procedure 
of Darrow and Rodstrom (3). Protein was estimated by the method 
of Lowry et al. (18). Polyacrylamide gel electrophoresis was carried 
out according to  the method of Davis (19). 
Modification Procedures-Patthy and Smith (12) had shown that 
1,2-cyclohexanedione reacts specifically with a guanidino group of 
arginine residues at pH 8-9 in sodium borate buffer in the tempera- 
ture range of  25-40 “C. The borate ions are necessary to stabilize the 
reaction product. We could not use borate buffer because of an 
inhibitory effect of high concentrations of borate ions on the enzyme 
activity. The reason for this inactivation of the enzyme was not 
investigated. Modification experiments using either 1,2-cyclohex- 
anedione or 2,3-butanedione were, therefore, performed in 0.05 M 
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Hepes' buffer, pH 8.0, that contained 2-5 mM sodium borate. The 
borate ions at these low concentrations did not react significantly 
with the enzyme in Hepes buffer. In all cases temperature was 
maintained at 28  "C. Modifications with phenylglyoxal was carried 
out in 0.02 M sodium phosphate buffer, pH 8.0, a t  28 "C. Phenyl- 
glyoxal solution was made in dimethyl sulfoxide. Dimethyl sulfoxide 
did not have any effect on epimerase activity. Control experiments 
without modifying reagents were always run. All the reagents (1,2- 
cyclohexanedione, borate, 2,3-butanedione, phenylglyoxal, and di- 
methyl sulfoxide) were tested on UDP-glucose dehydrogenase, the 
coupling enzyme of the coupled assay procedure, and no effect was 
observed at  the concentrations being transferred to  the assay medium. 
For stoichiometric and other calculations, the dimeric holoenzyme 
was assumed to have a molecular weight of 125,000 (3). 
Reactivation of 1,2-Cyclohexanedione and Z3-Butanedione-inhib- 
was taken in 25  pl of 0.05 M Hepes buffer, pH 8.0, and incubated with 
ited Enzyme-For a typical reactivation experiment, 15 pg  of enzyme 
4 mM borate and 10 mM 1,2-cyclohexanedione for 1 h at 28  "C. Then 
5 pl of inactivated enzyme having 20% residual activity was trans- 
ferred to 50  pl  of Tris-HC1 buffer and incubated for 2 h at  the same 
temperature. A control sample containing 4 mM borate was kept 
under identical conditions in Hepes buffer, and  the percentage of 
activity was calculated by comparing the activity in the control tube. 
The enzyme modified by 2,3-butanedione (2 mM) under similar ex- 
perimental conditions was also reactivated up to 50% of initial activity 
from 20% residual activity by simple dilution with 0.05 M Hepes 
buffer of the same pH. Epimerase inactivated by phenylglyoxal, 
however,  could not be reactivated. 
Estimation of NAD in Arginine-modified Enzyme-Estimation of 
NAD bound to  the inactivated enzyme was carried out  in the following 
manner. One hundred fifty-six micrograms (1.3 nmol) of the enzyme 
in 0.13  ml of  0.02 M sodium phosphate buffer, pH 8.0, were incubated 
with 2 mM phenylglyoxal for 30 min at 27°C to ensure complete 
modification. The modified enzyme with 15% residual activity was 
passed through a Sephadex G-50 column (0.8 X 20 cm) to remove 
excess reagents and any presumed dissociated NAD. The protein 
eluant was denatured with 70% alcohol. The alcoholic supernatant 
was evaporated to dryness and redissolved in a minimal volume of 
water. NAD content of that solution was measured fluorimetrically 
after converting to a highly fluorescent product in strong alkali (20). 
The control enzyme sample containing the vehicle dimethyl sulfoxide 
in absence of phenylglyoxal was treated  in a similar way. 
Determination of Molecular Weight of Modified Enzyme-Three 
hundred micrograms (2.4 nmol) of the enzyme in 0.25 ml of 0.02 M 
sodium phosphate buffer, pH 8.0, were incubated with 2 mM phenyl- 
glyoxal for 1 h at 27 "C to ensure complete modification. The modified 
enzyme with 15% residual activity was applied to a previously cali- 
brated Sephadex G-200 column (1.5 X 51 cm) pre-equilibrated with 
0.02 M sodium phosphate buffer, pH 8.0, and eluted with the same 
buffer. The enzyme eluted  in the same position as  the native enzyme. 
RESULTS 
Inactivation of UDP-glucose 4-Epimerase by Phenyl- 
glyoxal-Incubation of epimerase with phenylglyoxal resulted 
in a progressive loss of enzyme activity. The inactivation 
followed a pseudo first order kinetics to 15% of the initial 
activity (Fig. 1). The enzyme could not be inactivated com- 
pletely even after prolonged incubation with much higher 
concentrations of the reagents. The second order rate con- 
stant for the inactivation was  12.5  min-' i"'. A plot of log k 
(pseudo first order rate  constant) uersus log [phenylglyoxal] 
(21) resulted in a straight  line with a slope of 1.8 (Fig. 1, inset) 
indicating that  at least 2 mol  of phenylglyoxal/mol of enzyme 
was required to produce inactivation. 
Inactivation of Epimerase with 1,2-Cyclohexanedione and 
2,3-Butanedwne-Both 1,2-~yclohexanedione  and 2,3-bu- 
tanedione  inactivated the epimerase activity (Figs. 2 and 3). 
But  as with phenylglyoxal inactivation, the enzyme always 
had some residual activity even after prolonged incubation 
with much higher concentrations of these reagents and also 
' The abbreviations used are: Hepes, 4-(2-hydroxyethyl)-l-pipera- 
zineethane sulfonic acid; ANS, 1-anilino-%naphthalene sulfonic acid. 
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FIG. 1. Inactivation of UDP-galactose  4-epimerase by 
phenylglyoxal. The enzyme (50 pg/ml) was incubated in different 
tubes with varying concentrations of phenylglyoxal in 0.02 M sodium 
phosphate buffer, pH 8.0, a t  28 "C. The control  tube having dimethyl 
sulfoxide only was incubated under identical conditions. At the indi- 
cated times aliquots were removed for measurements of enzyme 
activity. The phenylglyoxal concentrations in various runs were 0.4 
mM (a), 0.6 mM (o), 0.8 mM (A) and 2 mM (A). Inset,  plot of the log 
of pseudo first order rate constant ( k )  of phenylglyoxal inactivation 
reaction versus log of phenylglyoxal concentration. 
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FIG. 2. Inactivation of UDP-galactose  4-epimerase by 1,2- 
cyclohexanedione. The enzyme (75 pg/ml) was incubated in differ- 
ent tubes with varying concentrations of 1,2-cyclohexanedione in 0.05 
M Hepes buffer, pH 8.0, at 28 "C. The concentration of borate  in each 
tube was adjusted to 5 mM by adding sodium borate buffer of the 
same pH. At the indicated times aliquots were  removed for measure- 
ments of enzyme activity. Control enzyme was incubated under 
identical conditions without 1,2-~yclohexanedione. The concentra- 
tion of borate  in the control tube was also 5 mM. 1,2-Cyclohexane- 
dione concentrations were 3 mM (O), 4 mM (a), 5 mM (A), and 6 mM 
(A), respectively. Inset,  plot of  log  of pseudo first order rate  constant 
( k )  of the 1,2-cyclohexanedione inactivation reaction versus log of 
1,2-cyclohexanedione concentration. 
of borate ions (8 mM). Inactivation by these reagents also 
followed pseudo first order kinetics. 
The second order rate constant for inactivation by 1,2- 
cyclohexanedione ws 3.4 min-l M-' and  that of 2,3-butane- 
dione was 25 min-' M-'. Hence reactivity toward epimerase is 
much higher for 2,3-butanedione than phenylglyoxal, and 
phenylglyoxal reactivity is again much higher than 1,2-cy- 
clohexanedione. Since the kinetic order of inactivation was 
close to one in  both cases (1.2 for 1,2-cyclohexanedione and 
1.0 for 2,3-butanedione (Figs. 2 and 3, insets)), the minimal 
number of arginine residues that  are involved in  the inacti- 
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FIG. 3. Inactivation of UDP-galactose 4-epimerabe by 2,3- 
butanedione. The enzyme (75 pg/ml) in 0.05 M Hepes buffer, pH 
8.0, was incubated  in  different  tubes with 0.37 mM m), 0.63 mM (U), 
0.73 mM (a), and 1.12 mM (0) 2,3-butanedione at  28 “C. The concen- 
tration of borate in each  tube was adjusted to 5 mM by adding sodium 
borate  buffer of the same  pH. At the indicated times aliquots were 
removed for measurements of enzyme activity. Control enzymes were 
incubated  under  identical conditions without 2,b-butanedione. The 
concentration of borate in  the control enzyme was also 5 mM. Inset, 
plot of log of pseudo first order rate  constant ( k )  of the 2,3-butane- 
dione inactivation  reaction versus log of 2,3-butanedione concentra- 
tion. 
vation process can be taken  to be  one. The limitation of the 
kinetic method for determination of the number of essential 
amino acid residues and also of stoichiometry of a reaction 
was originally indicated by Levy et al. (21) and was further 
elaborated by Hayman and Colman (17). 
Reactivation of 1,2-Cyclohexanediom and 2,3-Butanedione- 
inhibited Enzyme-Enzyme inactivated by the diones have 
often been found to be reactivated in the presence of nucleo- 
philic buffers like Tris-HC1 (12), providing additional evi- 
dence in favor of modification of arginyl residues. Epimerase 
having 20% residual activity after inactivation with 1,2-cy- 
clohexanedione was reactivated up  to 50% of initial activity 
on  incubation with 0.05 M Tris-HC1 buffer, pH 8.2, containing 
1 mM EDTA for 2 h (details given under “Experimental 
Procedures”). 
Structural  Integrity of the Inactivated Enzyme-In order to 
find  out  whether the inhibition of epimerase activity due to 
the modification of arginyl residue was the result of detach- 
ment of  NAD from the enzyme, direct estimations of NAD 
through the fluorimetric procedure were carried out. More 
than 90%  NAD was estimated to be present  in phenylglyoxal- 
inhibited enzyme (details given under  “Experimental Proce- 
dures”). The dimeric structure of the native  protein remained 
unaffected on  treatment with phenylglyoxal as was revealed 
by determining the molecular weight of the inactivated  en- 
zyme on a  calibrated Sephadex G-200 column (details given 
under  “Experimental Procedures”). 
The K, for UDP-galactose for the enzyme inactivated with 
phenylglyoxal increased from 1.2 X to 4.5 X loe4 M. The 
coupled assay procedure of Darrow and Rodstrom (3) was 
employed for the determination of these values. 
Protection against Inactivation by Phenylglyoxal-Pal and 
Bhaduri (22) had shown that  UMP  is powerful competitive 
inhibitor for the yeast enzyme. These  authors  further showed 
that other uridine phosphates can also inhibit the enzyme 
competitively but less powerfully. The kinetic parameters 
were independently determined by us. All these competitive 
inhibitors and substrates were found to protect epimerase 
activity against  inactivation by phenylglyoxal approximately 
according to their affinity for the active site  (Table I). The 
results  further showed that uridine did not  act  as  a competi- 
tive inhibitor for the enzyme with UDP-galactose as the 
substrate  and hence probably had no binding interaction at 
the substrate-binding region of the active site. Consistent 
with  this observation, it failed to provide any protection to 
the enzyme against inactivation by phenylglyoxal (Table I). 
When the concentration of 5’-UMP was raised to 5 mM, 
effectively complete protection of the enzyme was observed 
even on prolonged incubation with phenylglyoxal. Because of 
the free reversibility of the reaction, UDP-glucose and  UDP- 
galactose are equivalent, and protection by substrate was 
tested under equilibrium conditions. The little amount of 
substrate  transferred along with the aliquot to  the assay media 
had no additional effect on enzymic rate. Protection experi- 
ments could not be performed in case of 1,2-~yclohexanedione 
and 2,3-butanedione inactivation due to  the reaction of borate 
ion with the sugar portion of substrates and competitive 
inhibitors. 
Experiments with [7-14C]Phenylglyoxal-Once we could 
demonstrate that complete protection was afforded by 5’- 
UMP  (5 mM), it provided us with a method to specifically 
label the arginine residues at the active site and also to 
estimate  quantitatively the  total number of arginine residues 
modified by  phenylglyoxal. Surprisingly, we found that even 
after complete modification only 1.7 nmol of [7-14C]phenyl- 
glyoxal was incorporated per nmol of the dimeric enzyme 
(Table 11). When the enzyme was protected with 5’-UMP, 
very little radioactivity was incorporated, indicating further 
that no arginyl residue outside the UMP-binding region re- 
acted with phenylglyoxal. In epimerase preincubated with cold 
phenylglyoxal in  the presence of 5’-UMP  and  then  treated 
with [7-14C]phenylglyoxal after making it free from UMP  and 
excess cold phenylglyoxal, about 1.9 nmol of radiolabeled 
phenylglyoxal was incorporated per nmol of the dimeric en- 
zyme (Table 11). These results further confirmed that the 
arginine residue(s) that reacted with 2 mol of phenylglyoxal 
could be completely protected in  the presence of 5’-UMP and 
are, therefore, possibly located at  the substrate-binding region 
of the dimeric holoenzyme. 
Location of the Arginine Residue on the Enzyme Surface- 
TABLE I 
Protection of epimerase by substrate and competitive inhibitors 
against phenylglyoxal inactivation 
The enzyme (5.4  pg) in 0.1 ml of  0.02 M sodium phosphate buffer, 
pH 8.0, was incubated with 1 mM competitive inhibitor and 2 mM 
phenylglyoxal at 28 “C.  The rate of inactivation was followed by 
transferring 10-pl aliquots to  the assay medium at  various times and 
the  rate  constant calculated. For the substrate protection experiment 
6 pg of enzyme in 15 pl of  0.02 M sodium phosphate buffer, pH 8.0, 
was preincubated with 1.1 mM UDP-galactose for 10 min. 2 mM 
phenylglyoxal was then added and again incubated at  28 ‘ C .  The rate 
of inactivation was followed  by transferring the 1-pl aliquot to  the 
assay medium at  various times and  the  rate  constant calculated. The 
K,,, for UDP-galactose and K j  for the uridine phosphates were inde- 
pendently determined by us by employing the assay procedure of 
Darrow and Redstrom (3). 
Protecting  agents (1 mM) Ki of competitive Inhibition rate inhibitors constants, K 
mM min” 
None 0.032 
Substrate (UDP-galactose) K,,, 0.10 0.009 
0.15 
5’-UMP (5 mM) 
0.009 
0.15 
UDP 
0.001 
0.37 
UTP 
0.015 
0.6 
Uridine 
0.024 
0.030 
5”UMP 
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TABLE I1 
Incorporation of [7-14C]phenylglyoxal to epimerase in absence and 
presence of 5‘- UMP 
For a and b, epimerase (0.6 nmol) in 0.1 ml of 20 mM sodium 
phosphate buffer, pH 8.0, was incubated  with [7-’4C]phenylglyoxal (1 
mM) (8 X lo6 counts/s/pmol) a t  27 “c for  2 h. In b 5’-UMP (5 mM) 
was kept  in  the  incubation media. After  ensuring desired modification 
a  having 15% residual activity  and b having 80% activity was  passed 
separately  through a Sephadex G-50 column (0.6 X 33 cm) for 
removing  excess reagent  using 20 mM sodium phosphate  buffer, pH 
8.0, as  eluent.  The  eluate was analyzed for  radioactivity incorporated 
to  the enzyme. For  c,  epimerase (1.1 nmol)  in 0.02 M sodium phos- 
phate buffer, pH 8.0, was incubated  with 10 mM 5’-UMP  and 1 mM 
cold phenylglyoxal a t  27 “C for  2 h. The enzyme having 80% activity 
was then passed through a Sephadex G-50 column (0.6 X 33 cm) 
using 0.02 M sodium phosphate buffer, pH 8.0, as  eluent for  removing 
UMP  and excess  phenylglyoxal. The eluate was assayed  for  enzyme 
activity and  protein  content.  From  the  tube  having  highest  protein 
concentration, 0.3 ml of solution  with 30 pg of enzyme (0.25 nmol) 
was incubated with 1 mM [7-’4CJphenylglyoxal for 2 h a t  27 “C to 
ensure complete  modification. The modified  enzyme with 15% resid- 
ual activity was again  passed  through a Sephadex G-50 column  for 
removing excess reagent. The eluate was analyzed for radioactivity 
bound to  the  protein.  The molecular weight of the dimeric  enzyme 
was assumed  to be 125,000 as  reported  earlier by Darrow  and Rod- 
strom (3). 
Condition 
Nmol of [7-’4C]phenylglyoxal 
incorporated per nmol of di- 
meric holoenzyme 
(a) Completely modified epimerase  in 1.7 
(b)  Epimerase modified by [7-I4C] 0.18 
absence of 5’-UMP 
phenylglyoxal in  presence of 5‘- 
UMP 
UMP-binding region 
(c)  Epimerase specifically  labeled a t  1.9 
Wong and Frey (23) were the first to demonstrate that 1- 
anilino-&naphthalene sulfonic acid (ANS) could react  with 
the E. coli epimerase  to show an enormously enhanced fluo- 
rescence and a blue shift of 40 nm. Further, the extrinsic 
fluorophore was specifically directed toward the substrate- 
binding  site,  and  the  interaction could be  prevented by UMP 
and  other  uridine nucleotides. This  observation was extended 
to  the S. fragilis enzyme by Samanta  and  Bhaduri (24). These 
results suggest that  the  extrinsic fluorophore can be utilized 
to  monitor  the  substrate-binding region of the  active  site of 
the S. fragilis enzyme. When  such  an  experiment was carried 
out with the enzyme, inactivated by phenylglyoxal, a very 
marked reduction in the enhancement of fluorescence was 
observed (Fig. 4). This was evidently due to the impaired 
interaction of the fluorophore with  the  substrate-binding  re- 
gion of the enzyme as  protection by UMP  during  treatment 
with phenylglyoxal could show  a  full enhancement of fluores- 
cence for the probe  (Fig. 4).  ANS  interaction was also  found 
to be decreased after modification by 1,2-cyclohexanedione 
(data  not  shown). 
Epimerase from S. fragilis is  unique  in  that  it  exhibits  an 
intense and characteristic NADH-like fluorescence with an 
apparant blue shift  having  an emission maxima a t  435 nm  on 
excitation at  353  nm. The exact chemical nature of the 
fluorophore is  not known. Apparently,  the  pyridine moiety of 
NAD in combination  with some amino acid residues at  the 
catalytic region of the  active  site  acts  as  the fluorophore  (25). 
Whatever  is  the  nature of this  intrinsic fluorophore, it  pro- 
vides  a direct  monitor of the  changes  at  the  active  site of the 
enzyme. In phenylglyoxal-inactivated  enzyme, the  native flu- 
orescence was found  to be enhanced  three  times  that of the 
control enzyme and if the enzyme was protected by UMP 
against  inactivation by the  reagent,  no  detectable  change in 
2001 
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FIG. 4. Interaction of ANS with phenylglyoxal-inactivated 
enzyme. In  three  tubes 100 pg of epimerase was taken  in 300 p1 of 
0.02 M sodium phosphate buffer, pH 8.0. To tube 2 4 mM phenyl- 
glyoxal was  added and  to  tube 3 3 mM 5’-UMP  and 4 mM phenyl- 
glyoxal were added. To tube 1 only dimethyl sulfoxide was added 
which served as control. The tubes were incubated a t  28 “C for 20 
min.  The  solutions were then dialyzed against 0.02 M sodium phos- 
phate buffer, and fluorescence measurements were carried  out  with 
those dialyzed enzymes. The excitation was at  375 nm. 1, 100 pM 
ANS; 2, enzyme  before adding ANS; 3, control enzyme treated with 
100 p~ ANS; 4,  phenylglyoxal-inactivated  enzyme treated  with 100 
p~ ANS; 6, enzyme protected by 5’-UMP against inactivation by 
phenylglyoxal treated  with 100 p~ ANS. 
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FIG. 5. Fluorescence properties of phenylglyoxal-inacti- 
vated enzyme. The dialyzed phenylglyoxal-treated enzymes ob- 
tained  as described in Fig. 4 were excit,ed a t  353 nM and  the fluores- 
cence spectrum recorded. Lower tracings,  co-enzyme  fluorescence of 
control and 5’-UMP-protected enzyme. Upper tracing, co-enzyme 
fluorescence of phenylglyoxal-inactivated enzyme. 
the  nature  and  extent of fluorescence  could be observed (Fig. 
5). I t  is possible that the incorporation of the phenyl ring 
near the pyridine moiety of NAD makes the environment 
more  hydrophobic and hence the  enhancement.  Whatever  is 
the  exact cause of this  enhancement,  it  is clear that  at  least 
one modified arginine residue is physically  located near  the 
catalytic region of the  active  site. 
DISCUSSION 
The  kinetic  method of Levy et al. (21) has been utilized by 
several  groups of workers to  determine  the  minimal  number 
of functionally essential arginine residues for different en- 
zymes (15, 26-28). For  the  yeast  epimerase,  all  the  three 01- 
dicarbonyl reagents were effective, but  in each  case the  final 
product was an enzyme species which retained 15% of the 
original  activity. Though phenylglyoxal  occasionally lacks  in 
specificity, the  other two reagents  are fairly specific for argi- 
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nine (12,  29). The partial  but definite regeneration of activity 
of 1,2-cyclohexanedione-inactivated enzyme in nucleophilic 
buffer and of 2,3-butanedione-inactivated enzyme on removal 
of borate by dilution  is  consistent  with modification of argi- 
nine residues on the enzyme surface. Such reversibilities had 
earlier been demonstrated for some other enzymes (12,  15). 
As regards the number of arginine residues that  are essential 
for catalytic activity there  exists some uncertainty. Stoichio- 
metric experiments with radiolabeled phenylglyoxal (Table 
11) show that 2 mol of the reagent react with the active dimeric 
holoenzyme. If 1:l stoichiometry is assumed for phenylglyoxal 
to arginine, as  has been shown for many enzymes (13-E), 
there  are two essential  arginine residues on  the enzyme sur- 
face. In contrast, if 2:l stoichiometry is assumed, as was 
originally shown to occur with free arginine by Takahashi 
(10) and was subsequently shown to occur for several enzymes 
(30, 31), only one essential arginine residue appears to be 
involved in the catalytic activity of the enzyme. Notwith- 
standing  these difficulties, the simplest  interpretation of the 
data obtained from experiments with radiolabeled phenyl- 
glyoxal and also from kinetic analysis with all the three 
dicarbonyl reagents would be to assume the presence of a 
minimum of one arginine residue that is essential for the full 
catalytic activity of the enzyme. Direct estimation of NAD 
content  and also determination of molecular weight of the 
phenylglyoxal-modified enzyme by gel filtration clearly 
showed that  the structural integrity of the holoenzyme re- 
mained unaffected, and  the loss of activity was exclusively 
due to  the modification of at least one arginine residue on  the 
enzyme surface. When  such modifications lead to a change in 
tertiary  structure, the direct cause for inactivation  remains 
uncertain. The S. fragilis enzyme was earlier shown to become 
inactive, either due to ejection of the coenzyme from the 
dimeric epoenzyme on controlled heating (32) or due to dis- 
sociation of the dimer on treatment  withp-chloromercuriben- 
zoate (32,  33). 
The active sites of S. fragilis enzyme can be arbitrarily but 
conveniently grouped into three regions, namely the sub- 
strate-binding region, the coenzyme-binding region, and  the 
catalytic region comprising of the hexose moiety of the sub- 
strate and the pyridine moiety of the coenzyme, the two 
moieties that actively participate  in the hydride transfer proc- 
ess. The characteristic pyridine fluorescence of the enzyme 
may be regarded as  a  direct  monitor of the catalytic region. 
UMP, on the other hand, is an excellent monitor for the 
substrate-binding region of the active site. Extensive work 
with  both the S. fragilis and  the E. coli enzyme from several 
laboratories on the process of “reductive inhibition,” a  phe- 
nomenon in which UMP in combination with various free 
sugars slowly inactivates the enzyme, leaves little  doubt that 
UMP specifically interacts with the substrate-binding region 
of the active site of epimerase from these sources (1, 2). The 
graded protection of activity with the  substrate  and  the com- 
petitive inhibitors (Table I), the complete reversal of en- 
hanced fluorescence of the substrate site-directed extrinsic 
amionic fluorophore on addition of UMP (Fig. 4), and  the 
failure to radiolabel the enzyme in the presence of UMP 
(Table 11) all strongly indicate that  the arginine residue is 
physically located in  the substrate-binding region of the active 
site. In  contrast to UMP, uridine does not  act  as a competitive 
inhibitor for the enzyme (Table I) nor is it capable of replacing 
UMP in the “reductive inhibition” phenomenon (1). Presum- 
ably, the phosphate moiety of UMP is critically involved in 
the binding of the ligand to  the enzyme. It is  not unlikely, 
therefore, that  the cationic arginine residue at  the substrate- 
binding region is involved in an interaction with the a- 
phosphate moiety of the substrate. Such interactions of the 
arginine residues with the phosphate  portions of the substrate 
or coenzyme had earlier been documented for a number of 
enzymes (13, 17, 34-36). However, in  the absence of further 
evidence such  interaction for this enzyme remains somewhat 
speculative at  the moment. Interestingly, even after complete 
modification of the arginine residue by any of these dicarbonyl 
reagents, 15% of the initial enzyme activity was retained, and 
the K ,  for the  substrate for the modified enzyme increased 
significantly. Obviously, a weak but  partially effective inter- 
action can still take place between the substrate and the 
enzyme even after the arginine residue is modified. Such 
residual catalytic activity has been demonstrated for some 
other enzymes (37-39). Though the arginine residue is placed 
in the substrate-binding region, it must also be fairly close to 
the coenzyme fluorophore. Introduction of a phenyl group 
and increased hydrophobicity in  the region after modification 
may be the cause of the %fold enhancement of this fluores- 
cence (Fig. 5 ) .  However, since the  nature of the fluorescence 
spectrum remained unaltered,  any  direct role of the arginine 
residue in  maintaining the fluorophore structure  can be elim- 
inated. Such a role for a  thiolate  anion was assumed by Ray 
and  Bhaduri (25) from their fluorimetric studies with sulfhy- 
dryl-modifying reagents. 
We do not have any adequate explanation for the exclusive 
reactivity of the arginine residue at  the active site that was 
observed with phenylglyoxal as  the modifying reagent (Table 
11). The dimeric enzyme has a large number of arginine 
residues (3), and  it was expected that  at least a few of them 
would  be  exposed outward and would  be fairly reactive. An 
analogous situation was earlier observed by Takata  and Fu- 
jioka (31) for S-adenosyl homocysteinase from rat liver when 
they could show that only 2 arginine residues at  the active 
site out of the 14 available per subunit were reactive to 
phenylglyoxal. Interestingly, this enzyme, consisting of four 
identical subunits, also has a tightly bound NAD as the 
coenzyme at  the active site of each of the monomers (40). As 
the active site arginine is the only arginine residue that is 
modified  by phenylglyoxal, labeling of this residue followed 
by proteolytic cleavage provides for the  first time a direct 
method to sequence portions of the active site of this model 
oxidoreductase. 
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